Nucleotide substitution: ?1547?.
Amino acid replacement: Y333term.
muscle founder cell | embryonic stage
The eve-expressing DA1 founder cell undergoes limited fusion in snss660 embryos, but multiple eve-positive nuclei are present at stage 15-16.
snss660 has muscle founder cell | embryonic stage phenotype, non-enhanceable by rstirreC1
snss660 rstirreC1 embryos show a similar number of eve-positive DA1 founder cell nuclei as snss660 embryos at stage 15-16.
From Elizabeth Chen.
From Elizabeth Chen.